Thoracic surgery theses enjoyed a publication rate that amounted to 385% of all. Earlier than anticipated, the women researchers publicized their findings in scientific journals. Articles from SCI/SCI-E journals exhibited a higher rate of citation. In experimental/prospective studies, the period from study completion to publication was significantly condensed. This research, a bibliometric study of thoracic surgery theses, stands as the first of its kind in the existing literature.

Existing research on the results of eversion carotid endarterectomy (E-CEA) utilizing local anesthetic techniques is scarce.
We aim to determine postoperative outcomes for E-CEA under local anesthesia, then compare them with those for E-CEA/conventional CEA under general anesthesia, in individuals presenting with either symptomatic or asymptomatic conditions.
The study population consisted of 182 patients (143 male, 39 female) who underwent either eversion or conventional CEA with patchplasty under general or local anesthesia, at two tertiary referral centers, with ages ranging from 47 to 92 years (mean age 69.69 ± 9.88 years). Data were collected from February 2010 to November 2018.
In conclusion, the full in-hospital duration.
Under local anesthesia, E-CEA resulted in a significantly shorter postoperative in-hospital stay compared to other procedures (p = 0.0022). Major stroke affected 6 patients (32%), with 4 (21%) fatalities. Cranial nerve damage, specifically the marginal mandibular branch of the facial nerve and the hypoglossal nerve, occurred in 7 patients (38%). Post-operative hematomas developed in 10 patients (54%). No disparity was observed regarding postoperative strokes.
The tragic outcome of surgery, including fatalities categorized as postoperative deaths (code 0470).
Instances of postoperative bleeding were recorded at a rate of 0.703.
Damage to cranial nerves, either pre-operative or a complication of the cranial operation, was established.
A disparity of 0.481 exists between the groups.
Local anesthesia during E-CEA procedures resulted in reductions in mean operative time, the length of in-hospital stay after surgery, the overall duration of in-hospital stay, and the necessity for shunting procedures. E-CEA performed under local anesthesia exhibited a trend toward improved outcomes in stroke, mortality, and bleeding, though no statistically significant difference was observed.
Patients undergoing E-CEA under local anesthesia exhibited reduced mean operative time, postoperative hospital stay, total hospital stay, and shunting requirements. E-CEA performed under local anesthesia, while potentially favorable in terms of stroke, death, and bleeding complications, did not demonstrate statistically significant results.

In a group of patients with varying stages of lower extremity peripheral artery disease, we present preliminary results and real-world observations on the utilization of a novel paclitaxel-coated balloon catheter in this study.
The pilot study employed a prospective cohort design, recruiting 20 patients with peripheral artery disease who received endovascular balloon angioplasty with BioPath 014 or 035; a novel, paclitaxel-coated, shellac-infused balloon catheter. A total of thirteen TASC II-A lesions were found in eleven patients; six patients had a total of seven TASC II-B lesions; two patients presented with TASC II-C lesions; and finally, two more patients exhibited TASC II-D lesions.
A single BioPath catheter insertion successfully addressed twenty target lesions in thirteen patients. Seven patients, conversely, needed more than one attempt using a different size catheter. In five patients, the target vessel's total or near-total occlusion was initially addressed using a chronic total occlusion catheter of suitable size. In 13 (65%) patients, there was at least one observed categorical improvement in their Fontaine classification, with none experiencing symptomatic worsening.
As a treatment for femoral-popliteal artery disease, the BioPath paclitaxel-coated balloon catheter seems to be a useful alternative to comparable medical devices. The safety and efficacy of the device must be further investigated, building upon these preliminary results.
The BioPath paclitaxel-coated balloon catheter is demonstrably a useful alternative treatment for femoral-popliteal artery disease when compared to similar devices. To establish the safety and effectiveness of the device, further investigation into these preliminary findings is necessary.

A rare, benign condition, thoracic esophageal diverticulum (TED), is linked to esophageal motility issues. Thoracic surgery, often involving the excision of the diverticulum, either via traditional thoracotomy or minimally invasive methods, constitutes the standard treatment, with mortality rates generally falling between zero and ten percent.
The surgical outcomes of treating esophageal thoracic diverticula, as observed over a 20-year timeframe, are presented.
Surgical interventions for patients harboring thoracic esophageal diverticula are examined retrospectively in this study. All patients received the surgical treatment of open transthoracic diverticulum resection, including the myotomy. Hepatoid carcinoma Patients were evaluated regarding the extent of their dysphagia difficulties before and after surgical interventions, encompassing accompanying complications and post-operative comfort levels.
The surgical treatment of thoracic esophageal diverticula was undertaken in twenty-six cases. Diverticulum resection was performed in association with esophagomyotomy in 23 (88.5%) cases. In seven (26.9%) patients, anti-reflux surgery was the procedure, and in three patients (11.5%) with achalasia, no resection was performed. Following surgery, a fistula formed in 2 patients (77%), both of whom needed mechanical ventilation. In one patient, the fistula healed naturally, while the other necessitated esophageal removal and colonic reconstruction. Two patients experiencing mediastinitis required urgent, emergency treatment. No deaths were observed during the patient's time in the hospital's perioperative care.
A clinical quandary arises in the treatment of thoracic diverticula. The patient's life is at immediate risk due to postoperative complications. The functional performance of esophageal diverticula is usually excellent over the long term.
Thoracic diverticula treatment represents a complex and taxing clinical concern. The patient's life faces a direct threat from postoperative complications. Long-term functional outcomes associated with esophageal diverticula are generally positive.

Infective endocarditis (IE) on the tricuspid valve usually requires a complete removal of the infected tissue and the addition of a prosthetic valve.
We reasoned that substituting artificial material with solely patient-derived biological material would lessen the occurrence of infective endocarditis recurrence.
Seven patients, in sequential order, underwent the procedure of having a cylindrical valve, originating from their own pericardium, implanted into their tricuspid orifice. Biogas yield Only men between the ages of 43 and 73 were present. A pericardial cylinder was used for the reimplantation of the isolated tricuspid valves in two patients. Further procedures were required for five (71%) of the patients. The postoperative monitoring period extended from a minimum of 2 months to a maximum of 32 months, with a median follow-up of 17 months.
Patients implanted with isolated tissue cylinders experienced an average duration of 775 minutes for extracorporeal circulation and an average aortic cross-clamp time of 58 minutes. Additional procedures necessitated ECC and X-clamp times of 1974 and 1562 minutes, respectively. Post-ECC extubation, transesophageal echocardiography determined the implanted valve's function. This was further corroborated by transthoracic echocardiography 5 to 7 days post-surgery, demonstrating normal prosthetic function in every patient. There was no loss of life associated with the surgical procedure. Two individuals met with a late demise.
During the period of follow-up, no patient presented a recurrence of IE within the pericardial cylinder. Degeneration in the pericardial cylinder, subsequently resulting in stenosis, was observed in three patients. A subsequent operation was performed on one patient; one patient received a transcatheter valve-in-valve cylinder implantation procedure.
Subsequent to the initial treatment, none of the patients suffered from infective endocarditis (IE) returning within the pericardial area. Degeneration of the pericardial cylinder, resulting in stenosis, was observed in three patients. One patient underwent a further surgical procedure; a separate patient had a transcatheter valve-in-valve cylinder implanted.

Thymectomy is a well-established therapeutic option, serving as a cornerstone within the multidisciplinary approach to treating non-thymomatous myasthenia gravis (MG) alongside thymoma. Although alternative thymectomy methods abound, the transsternal technique is still considered the premier option. Cediranib Minimally invasive procedures have, in the last several decades, achieved widespread acceptance and are now extensively employed in modern surgical practice within this sector. Robotic thymectomy, among the surgical procedures, has garnered the most cutting-edge recognition. Meta-analyses and studies from several authors have shown that minimally invasive thymectomy procedures result in improved surgical outcomes and fewer complications than the open transsternal method, showing no substantial impact on complete myasthenia gravis remission rates. This literature review focused on describing and clarifying the techniques, advantages, outcomes, and future implications of robotic thymectomy. Early-stage thymoma and myasthenia gravis patients will likely benefit from robotic thymectomy, which emerging evidence suggests is destined to become the gold standard for this procedure. Minimally invasive procedures often present drawbacks, but robotic thymectomy appears to alleviate these issues, leading to satisfactory long-term neurological outcomes.